One of the least developed pharmaceutical markets in Asia, with low per capita spending on drugs. Counterfeit drugs account for a significant amount of market consumption. ...Complex drug pricing policy biased towards local drug producers. Import-reliant market, especially in terms of high-tech products and active pharmaceutical ingredients, which makes it vulnerable to currency movements. Underdeveloped primary care services and a shortage of trained pharmacists are continuing to hamper access to medicines and product market penetration. ...Underdeveloped primary care services and a shortage of trained pharmacists are continuing to hamper access to medicines and product market penetration. Population concentrated in rural, rather than urban, areas, preventing access to modern drugs and encouraging dependence upon traditional medicines.
...After the official lifting of Domesco s -- foreign ownership cap, US-based Abbott Laboratories, through its subsidiary CFR International (Chile), registered to increase its ownership in Domesco to --.- in September ---- from --.-- previously. In addition, Abbott acquired Vietnamese pharmaceutical manufacturer Glomed in August ----, reflecting Abbott s determination to strengthen its manufacturing capacity in Vietnam. ...After the official lifting of Domesco s -- foreign ownership cap, US-based Abbott Laboratories, through its subsidiary CFR International (Chile), registered to increase its ownership in Domesco to --.- in September ---- from --.-- previously. In addition, Abbott acquired Vietnamese pharmaceutical manufacturer Glomed in August ----, reflecting Abbott s determination to strengthen its manufacturing capacity in Vietnam. Also in August, French-based Sanofi signed an agreement to extend and strengthen its partnership with Vinapharm. ...Also in August, French-based Sanofi signed an agreement to extend and strengthen its partnership with Vinapharm. Covering all locally manufactured medicines marketed by Sanofi in Vietnam and products exported to countries in the Asia Pacific, the agreement includes Vinapharm investment in Sanofi s recent and third manufacturing plant in Vietnam (a USD--mn plant which represents Sanofi s largest investment in the market to date).
...� Business Monitor International Ltd Page - Pharmaceutical SWOT Analysis - Continued The Association of Southeast Asian Nations harmonisation initiative, including the adoption of Western regulatory standards such as International Conference on Harmonisation and WHO guidelines. Introduction of five-year exclusivity for clinical dossier data encouraging research- based multinationals. ...
